Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-09-16 4:23 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,301,551 23.3% | 622,496 (+4.55%) | View |
| 2022-09-16 2:27 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,071,703 9.6% | 484,496 (+8.67%) | View |
| 2022-08-15 4:59 pm Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,613,623 (Position Closed) | View |
| 2022-02-14 5:02 pm Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 2,727,249 5.5% | -625,032 (-18.64%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 2,613,623 5.3% | 2,613,623 (New Position) | View |
| 2022-02-14 3:13 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Cormorant Global Healthcare Master Fund LP | 3,565,901 7.23% | 974,987 (+37.63%) | View |
| 2022-02-09 09:11 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 2,500,099 5.071% | 2,500,099 (New Position) | View |
| 2022-01-13 4:28 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | CITADEL ADVISORS LLC | 2,489,284 5% | 30,761 (+1.25%) | View |
| 2022-01-13 4:27 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | CITADEL ADVISORS LLC | 2,458,523 5% | 3,199 (+0.13%) | View |
| 2021-07-12 4:07 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | CITADEL ADVISORS LLC | 2,455,324 5% | 2,455,324 (New Position) | View |
| 2021-05-18 4:08 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Cormorant Global Healthcare Master Fund LP | 2,590,914 5.26% | 2,590,914 (New Position) | View |
| 2021-04-30 6:44 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | U.S. Venture Partners XI L.P. | 3,489,168 7.1% | 3,489,168 (New Position) | View |
| 2021-04-07 6:00 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 13,679,055 27.8% | 13,679,055 (New Position) | View |
| 2021-04-05 3:20 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 3,352,281 7% | 3,352,281 (New Position) | View |
| 2021-03-31 4:31 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 5,587,207 11.4% | 5,587,207 (New Position) | View |
| 2021-03-30 3:40 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 3,933,137 8.27% | 3,933,137 (New Position) | View |